Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Viral RNA-dependent RNA polymerase mutants display an altered mutation spectrum resulting in attenuation in both mosquito and vertebrate hosts.

Warmbrod KL, Patterson EI, Kautz TF, Stanton A, Rockx-Brouwer D, Kalveram BK, Khanipov K, Thangamani S, Fofanov Y, Forrester NL.

PLoS Pathog. 2019 Apr 4;15(4):e1007610. doi: 10.1371/journal.ppat.1007610. eCollection 2019 Apr.

2.

Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir.

Comer JE, Escaffre O, Neef N, Brasel T, Juelich TL, Smith JK, Smith J, Kalveram B, Perez DD, Massey S, Zhang L, Freiberg AN.

Viruses. 2019 Feb 3;11(2). pii: E137. doi: 10.3390/v11020137.

3.

A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice.

Terasaki K, Juelich TL, Smith JK, Kalveram B, Perez DD, Freiberg AN, Makino S.

Sci Rep. 2018 Nov 20;8(1):17097. doi: 10.1038/s41598-018-35472-7.

4.

Natural History and Pathogenesis of Wild-Type Marburg Virus Infection in STAT2 Knockout Hamsters.

Atkins C, Miao J, Kalveram B, Juelich T, Smith JK, Perez D, Zhang L, Westover JLB, Van Wettere AJ, Gowen BB, Wang Z, Freiberg AN.

J Infect Dis. 2018 Nov 22;218(suppl_5):S438-S447. doi: 10.1093/infdis/jiy457.

PMID:
30192975
5.

Favipiravir (T-705) protects against Nipah virus infection in the hamster model.

Dawes BE, Kalveram B, Ikegami T, Juelich T, Smith JK, Zhang L, Park A, Lee B, Komeno T, Furuta Y, Freiberg AN.

Sci Rep. 2018 May 15;8(1):7604. doi: 10.1038/s41598-018-25780-3.

6.

Using click chemistry to measure the effect of viral infection on host-cell RNA synthesis.

Kalveram B, Lihoradova O, Indran SV, Head JA, Ikegami T.

J Vis Exp. 2013 Aug 9;(78). doi: 10.3791/50809.

7.

Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus.

Lihoradova OA, Indran SV, Kalveram B, Lokugamage N, Head JA, Gong B, Tigabu B, Juelich TL, Freiberg AN, Ikegami T.

PLoS Negl Trop Dis. 2013 Apr 18;7(4):e2181. doi: 10.1371/journal.pntd.0002181. Print 2013.

8.

Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice.

Indran SV, Lihoradova OA, Phoenix I, Lokugamage N, Kalveram B, Head JA, Tigabu B, Smith JK, Zhang L, Juelich TL, Gong B, Freiberg AN, Ikegami T.

J Gen Virol. 2013 Jul;94(Pt 7):1441-50. doi: 10.1099/vir.0.051250-0. Epub 2013 Mar 20.

9.

Toscana virus NSs protein promotes degradation of double-stranded RNA-dependent protein kinase.

Kalveram B, Ikegami T.

J Virol. 2013 Apr;87(7):3710-8. doi: 10.1128/JVI.02506-12. Epub 2013 Jan 16.

10.

Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR.

Kalveram B, Lihoradova O, Indran SV, Lokugamage N, Head JA, Ikegami T.

Virology. 2013 Jan 20;435(2):415-24. doi: 10.1016/j.virol.2012.09.031. Epub 2012 Oct 12.

11.

Functional analysis of Rift Valley fever virus NSs encoding a partial truncation.

Head JA, Kalveram B, Ikegami T.

PLoS One. 2012;7(9):e45730. doi: 10.1371/journal.pone.0045730. Epub 2012 Sep 19.

12.

The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation.

Aichem A, Kalveram B, Spinnenhirn V, Kluge K, Catone N, Johansen T, Groettrup M.

J Cell Sci. 2012 Oct 1;125(Pt 19):4576-85. doi: 10.1242/jcs.107789. Epub 2012 Jul 13.

13.

The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine.

Lihoradova O, Kalveram B, Indran SV, Lokugamage N, Juelich TL, Hill TE, Tseng CT, Gong B, Fukushi S, Morikawa S, Freiberg AN, Ikegami T.

J Virol. 2012 Jul;86(14):7650-61. doi: 10.1128/JVI.00778-12. Epub 2012 May 9. Erratum in: J Virol. 2013 Nov;87(22):12507.

14.

Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy.

Kalveram B, Lihoradova O, Indran SV, Ikegami T.

J Vis Exp. 2011 Nov 1;(57):e3400. doi: 10.3791/3400.

15.

NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62.

Kalveram B, Lihoradova O, Ikegami T.

J Virol. 2011 Jul;85(13):6234-43. doi: 10.1128/JVI.02255-10. Epub 2011 May 4.

16.

USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.

Aichem A, Pelzer C, Lukasiak S, Kalveram B, Sheppard PW, Rani N, Schmidtke G, Groettrup M.

Nat Commun. 2010 May 4;1:13. doi: 10.1038/ncomms1012.

PMID:
20975683
17.

Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.

Schmidtke G, Kalveram B, Groettrup M.

FEBS Lett. 2009 Feb 4;583(3):591-4. doi: 10.1016/j.febslet.2009.01.006. Epub 2009 Jan 21.

18.

The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition.

Kalveram B, Schmidtke G, Groettrup M.

J Cell Sci. 2008 Dec 15;121(Pt 24):4079-88. doi: 10.1242/jcs.035006. Epub 2008 Nov 25.

19.

The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10.

Schmidtke G, Kalveram B, Weber E, Bochtler P, Lukasiak S, Hipp MS, Groettrup M.

J Biol Chem. 2006 Jul 21;281(29):20045-54. Epub 2006 May 17.

20.

FAT10, a ubiquitin-independent signal for proteasomal degradation.

Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G.

Mol Cell Biol. 2005 May;25(9):3483-91.

Supplemental Content

Loading ...
Support Center